Skip to main content

Table 10 (abstract P223). Demographic and baseline characteristics of the treatment groups

From: 37th International Symposium on Intensive Care and Emergency Medicine (part 2 of 3)

Variable Citicoline WNH (N = 67) Control Austrian centers (N = 67) p
Sex, N (% male) 52 (78%) 50 (75%) 0.839
ISS, mean (SD) 27.4 (12.4) 31.7 (17.3) 0,1
Total GCS assessed at admission, mean (SD) 6.4 (4.7) 6.0 (4.2) 0.662
Pupillary reactivity in field, N (%)    0.702
Both reactive 41 (61%) 36 (54%)  
One reactive 2 (3%) 2 (3%)  
None reactive 3 (5%) 6 (9%)  
Unknown 21 (31%) 23 (34%)  
Pupillary reactivity at admission, N (%)    0.416
Both reactive 28 (42%) 29 (43%)  
One reactive 2 (3%) 5 (8%)  
None reactive 1 (2%) 3 (5%)  
Unknown 36 (54%) 30 (45%)  
Rotterdam CT score, N (%)    0.052
1 2 (3%) 2 (3%)  
2 22 (34%) 19 (31%)  
3 31 (48%) 17 (28%)  
4 7 (11%) 19 (31%)  
5 2 (3%) 3 (5%)  
6 0 1 (2%)  
Subarachnoid hemorrhage, N (% Yes) 39 (58%) 41 (61%) 0.861
Epidural hematoma, N (% Yes) 8 (12%) 13 (19%) 0,342
Subdural hematoma, N (% Yes) 37 (55%) 43 (64%) 0.379
Prehospital hypotension, N (% Yes) 1 (2%) 4 (6%) 0.328
Prehospital hypoxia, N (% Yes) 5 (8%) 12 (18%) 0.19
Prehospital intubation, N (% Yes) 33 (49%) 40 (60%) 0.057
Predicted six months mortality, mean % (SD) 30.7% (18.6) 33.4% (21.7) 0.682
Predicted six months unfav. outcome, mean % (SD) 51.8% (21.6) 53.9% (23.7) 0.626